RVNC - Revance Therapeutics Inc. (RVNC) CEO Daniel Browne on Q4 2018 Results - Earnings Call Transcript
Revance Therapeutics, Inc. (RVNC)
Q4 2018 Earnings Conference Call
February 26, 2019 4:30 PM ET
Company Participants
Jeanie Herbert - Senior Director of Investor Relations and Corporate Communications
Daniel Browne - President and Chief Executive Officer
Tobin Schilke - Chief Financial Officer
Abhay Joshi - Chief Operating Officer
Dustin Sjuts - Head of Commercial Aesthetics and Therapeutics
Conference Call Participants
Stacy Ku - Cowen and Company
David Amsellem - Piper Jaffray & Co.
Nicholas Rubino - Stifel, Nicolaus & Company
Myles Minter - William Blair & Company
Etzer Darout - Guggenheim Securities
Sean Hannan -